Physician profile
Bijoy E John
NPI 1467456228
$37,944.01
in general payments reported to CMS, 2019-2025
16 companies · $765 in 2025
The $765 reported for 2025 was more than what a typical Sleep Medicine (Internal Medicine) provider received nationally (typical 2025 total: $447).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $239 · 2021: $1,554 · 2022: $3,335 · 2023: $20K · 2024: $12K · 2025: $765.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $29K · Food and Beverage: $2,256 · Travel and Lodging: $1,708 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $28,546.88 |
| Food and Beverage | $2,255.53 |
| Travel and Lodging | $1,708.00 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Idorsia Pharmaceuticals US INC | $33,483.20 | 2022-2024 | Quviviq |
| Inspire Medical Systems, INC. | $1,521.37 | 2021-2025 | Inspire |
| Jazz Pharmaceuticals INC. | $1,234.02 | 2019-2025 | |
| Harmony Biosciences LLC | $739.13 | 2020-2025 | Wakix |
| Philips North America LLC | $348.95 | 2019-2023 | |
| Zoll Respicardia, INC. | $193.51 | 2022-2025 | Remede System |
| Avadel Cns Pharmaceuticals, LLC | $116.58 | 2024 | Lumryz |
| Abbvie INC. | $80.17 | 2021 | |
| Axsome Therapeutics, INC. | $78.74 | 2023-2024 | Sunosi |
| Amgen INC. | $36.28 | 2021-2022 | |
| Lilly USA, LLC | $24.39 | 2025 | Zepbound |
| Merck Sharp & Dohme LLC | $21.38 | 2022 | |
| Fisher & Paykel Healthcare INC | $18.91 | 2020 | |
| 3b Medical, INC. | $16.57 | 2023 | Luna |
| Eisai INC. | $16.38 | 2021 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Itamar Medical INC | $14.43 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bijoy John listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.